Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients By: CNBC.com News December 07, 2023 at 09:14 AM EST The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients By: CNBC.com News December 07, 2023 at 09:14 AM EST The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR. Read More >>